A cancer vaccine that might work? Moderna posts 'promising' early snapshot for Merck-partnered program and raids Bristol Myers for a new cancer R&D chief
Remember that personalized cancer vaccine Moderna was developing?
As the world awaits data from its late-stage Covid-19 candidate, the mRNA player is interrupting its most intensively watched program with an upbeat early snapshot of data from its messenger RNA cancer vaccine mRNA-4157. And the Moderna team is using the occasion to introduce a new chief for their oncology unit, raided from Bristol Myers Squibb’s cancer group.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.